COMMUNIQUÉS West-GlobeNewswire

Marketing Veteran Bryan Dulaney is advising SafeSpace Global on Growth Strategy
17/07/2026
NASHVILLE, TN., July 16, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), (“SafeSpace Global” or the “Company”), an AI-powered physical safety and monitoring platform for regulated care environments [...]
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
16/07/2026
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
16/07/2026
Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testing Supports iMDx's commercial strategy in transplant monitoring Final policy establishes recurring testing baseline [...]
Canadian Red Cross supports communities impacted by Ottawa flooding
16/07/2026
Funds raised will help people affected by the floods with their recovery OTTAWA, Ontario, July 16, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working closely with the City of Ottawa and community partners to [...]
NativePath 2026: Launch Effective Native Path Creatine Supplements for Seniors To Support Muscle Building and Strength with L-Leucine in USA
16/07/2026
Announcing NativePath Creatine Supplement combines creatine monohydrate, L-leucine, and L-carnitine to support muscle strength, recovery, energy, and lean muscle growth for an active lifestyle and daily wellness routine [...]
La Croix-Rouge canadienne vient en aide aux communautés frappées par les inondations à Ottawa
16/07/2026
Les sommes amassées soutiendront le rétablissement des personnes touchées par les inondations. OTTAWA, Ontario, 16 juill. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne travaille étroitement avec la Ville d’Ottawa [...]
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Trethera and UCLA Publish Comprehensive Review Highlighting Deoxycytidine Kinase as a Novel Metabolic Target for Cancer Therapy
16/07/2026
Peer-reviewed publication positions TRE-515 as the first clinically tested dCK inhibitor and outlines a new therapeutic framework for targeting nucleotide metabolism in tumors LOS ANGELES, July 16, 2026 (GLOBE NEWSWIRE [...]
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Society for Medical Decision Making Honors UMIT TIROL and Harvard Professor Uwe Siebert with 2026 Career Achievement Award
16/07/2026
OSLO, Norway, July 16, 2026 (GLOBE NEWSWIRE) -- The Society for Medical Decision Making (SMDM) presented its highest career honor, the 2026 Career Achievement Award , to Professor Uwe Siebert, MPH, MSc, ScD , of UMIT [...]
Former Smith+Nephew Global Orthopaedics President Craig Gaffin Joins MedEdge Holdings as Partner
16/07/2026
Healthcare industry veteran brings more than 25 years of commercial leadership experience to help expand MedEdge's platform for acquiring, building and commercializing innovative surgical technology companies GREENWICH [...]
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
16/07/2026
New initiative builds on EN3ZYME™ launch and highlights scalability of the Dapibus™ platform JUPITER, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a [...]
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
16/07/2026
One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX ® -C (immune globulin injection [human], 10% caprylate chromatography purified) plus standard medical treatment in patients with secondary [...]
CDT Equity Inc. Announces Reverse Stock Split
16/07/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-10 reverse stock split of [...]
BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral
16/07/2026
Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, July 16, 2026 ( [...]
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
16/07/2026
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, [...]
Diverge Health and Oakland Physician Network Services Announce Successful First-Year Partnership to Improve Quality of Care for Medicaid Patients in Michigan
16/07/2026
Deep clinical integration across 10 practices yields measurable improvements in quality outcomes and sets the stage for expanded shared savings and community health programming DETROIT, July 16, 2026 (GLOBE NEWSWIRE [...]
Theolytics Relocates to State-of-the-Art Facility at ARC Oxford to Drive Development of THEO-260 and Other Novel Oncolytic Immunotherapies
16/07/2026
Oxford UK, July 16th, 2026. Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, announces that it has relocated to new, state-of-the-art facilities at ARC Oxford, a [...]
Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV400, the Industry’s First Known CD22-Directed In Vivo CAR T Cell Therapy for Relapsed/Refractory B Cell Malignancies
16/07/2026
The company’s lead internal program expands its in vivo CAR T clinical pipeline for patients with relapsed/refractory B cell malignancies First patient expected to be dosed in Q3 2026 SEATTLE, July 16, 2026 (GLOBE [...]

Pages